ANTISENSE OLIGONUCLEOTIDES: A NEW TOOL IN NEUROSCIENCE
- 1 December 1994
- journal article
- review article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 21 (12) , 935-944
- https://doi.org/10.1111/j.1440-1681.1994.tb02655.x
Abstract
1. Recent studies have shown that gene expression can be selectively attenuated by administration of short sequences of nucleotides (oligonucleotides) that are complementary to a portion of messenger RNA coding for a particular gene product. 2. This technique is known as ANTISENSE, because the oligonucleotides are complementary to the mRNA which has the same sequence as the SENSE strand of DNA. 3. In the present review we focus, after a brief discussion of gene expression and mechanisms of action of ANTISENSE, on the methodological aspects of ANTISENSE experiments in neuroscience. In particular, we address the advantages, disadvantages and controls for the ANTISENSE technique, as well as the choice, design, mode of delivery, dose and storage of ANTISENSE oligonucleotides.Keywords
This publication has 69 references indexed in Scilit:
- Inhibition of RabSB expression attenuates Ca2+-dependent exocytosis in rat anterior pituitary cellsNature, 1993
- Antisense: into the brainThe Lancet, 1993
- Molecular mechanisms of pain: Serotonin1A receptor agonists trigger transactivation by c-fos of the prodynorphin gene in spinal cord neuronsNeuron, 1993
- Modulation of human prorenin gene expression by antisense oligonucleotides in transfected CHO cellsEuropean Journal of Biochemistry, 1993
- Overcoming Multidrug Resistance in Human Tumor Cells Using Free and Liposomally Encapsulated Antisense OligodeoxynucleotidesBiochemical and Biophysical Research Communications, 1993
- Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense OligodeoxynucleotidesScience, 1993
- Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brainEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Complete protection of antisense oligonucleotides against serum nuclease degradation by an avidin-biotin systemBioconjugate Chemistry, 1992
- Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomesCell, 1986
- 3′ Non-coding region sequences in eukaryotic messenger RNANature, 1976